Bifogade filer
Exercise of Warrants of Series TO 2023/2025:2 Provides Intellego Technologies AB (publ) with Approximately SEK 14.5 Million
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Intellego Technologies AB (publ) (“Intellego” or the “Company”) today announces the outcome of the exercise of warrants of series TO 2023/2025:2 (the “Warrants”), which were issued in July 2023. The warrants of series TO 2023/2025:2 were issued to an international institutional investor. All 322,581 warrants of series TO 2023/2025:2 have been exercised, resulting in the subscription of 322,581 shares. Each warrant of series TO 2023/2025:2 entitled the holder to subscribe for one new share in the Company at a price of SEK 45 per share. Through the exercise of the Warrants, Intellego receives approximately SEK 14.5 million before issuing costs.
Background
As of July 19, 2023, the Board of Directors, with the support of the authorization from the Annual General Meeting 2023, decided to carry out a directed issue of units (shares and warrants of series TO 2023/2025:2) to an international institutional investor. A total of 322,581 warrants of the aforementioned series were issued. Each warrant entitled the holder to subscribe for one (1) share at a price of SEK 45 per share during the period from June 16, 2025, to June 27, 2025. All warrants of series TO 2023/2025:2 have been exercised for the subscription of a total of 322,581 shares in Intellego. Through the exercise of the Warrants of series TO 2023/2025:2, Intellego receives approximately SEK 14.5 million before issuing costs. The original press release regarding the issuance of warrants of series TO 2023/2025:2 is available by clicking here.
Number of shares, share capital and dilution
Through the exercise of the Warrants the number of shares in Intellego increases by a total of 322,581 shares, from 30,417,814 shares to 30,740,395 shares and the share capital increases by approximately SEK 11,520.75, from approximately SEK 1,086,350.51 to approximately SEK 1,097,871.26. The exercise of the Warrants entails a dilution of approximately 1.05 percent of the total number of shares and votes.